Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein D from non-typeable Haemophilus influenzae is an outer membrane lipoprotein essential for bacterial virulence, possessing enzymatic activity that contributes to pathogenesis. Its high conservation across strains, strong immunogenicity, structural characterization, and proven efficacy as both an antigenic target and carrier molecule make it central to modern strategies combating respiratory tract infections through vaccination—most notably via its inclusion in multivalent pediatric vaccines like Synflorix™.
Serves as a carrier protein in conjugate vaccines, enhancing the immune response to polysaccharide antigens. Enzymatic activity releases phosphorylcholine, contributing to pathogenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein D from Non-typeable Haemophilus influenzae (Protein D).